The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.
about
Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseasesBotanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A ReviewAre cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic reviewInhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in miceCannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammationRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationCannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosisChemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer.Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model.Δ(9) Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells.HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid.The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitisAn Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse.Therapeutic Use of Cannabis in Inflammatory Bowel Disease.Cannabidiol in inflammatory bowel diseases: a brief overview.Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.Phytochemicals and their potential usefulness in inflammatory bowel disease.Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review.Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.Gut feelings about the endocannabinoid system.Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH).
P2860
Q26824588-1B2E0B55-E5A0-4C50-A362-7D194352625DQ26998841-4552A603-38C2-418E-8B2E-59D1EBCB6BEFQ27005619-8E994878-C700-4D4D-AD5D-3FEB3FD5C12AQ28258759-03A0C602-B63B-455D-952D-7E5B71CA301FQ28583653-FF3C25CA-FB8B-45B8-A431-41FA270829C0Q30357558-E78C9E77-224D-4DFE-A0F2-0BE9FD56356BQ33984006-E4ABDCD3-86F6-425C-BAAC-60138B53DD17Q34635002-8AA75F99-6636-4AF2-ACA5-EAD5B31E8F64Q34642592-40ECBCB8-0197-4B40-BAD0-0FB5EBFE889BQ35188151-822567A4-0EE2-451D-996B-DDCCADAA027EQ35223945-FEA792F3-1CF6-459F-A172-2735683AB205Q36077672-4FBD3783-2084-4722-9DAF-963993AC6A1FQ36784020-1AD83F70-49D9-483C-9CAA-8F94DF0E0F9DQ37306421-ED137FEA-C9A6-4183-A98E-4579439098A6Q37540208-A18F142E-170B-4B34-B379-69F923FA30D2Q38027809-73B8B47E-6E9D-4096-9316-3A55F3668F1CQ38212376-34ECB600-74EB-491F-8342-4A85BE615DDEQ38312093-F4515EC1-A8E0-4E57-856A-311648F1567EQ38503842-711E1777-3C5B-460E-B404-A88B65248933Q38918638-9EED05F8-92D5-4C67-949C-CFB01FA07F87Q38937293-8C431386-4AF9-4EB6-AE71-CCFB797BA8A2Q39025067-F66E4D29-9631-4700-AD5B-675709768CD5Q39213927-50D1D0FD-3393-4D86-8EC5-D8DB24EDB6FCQ39761953-6E537078-F37C-4344-BC18-3C333B8E5352Q42012570-A6215514-37D1-498A-85A3-5D5C5D53E2F0
P2860
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The effects of Delta-tetrahydr ...... y disturbances in rat colitis.
@en
The effects of Delta-tetrahydr ...... y disturbances in rat colitis.
@nl
type
label
The effects of Delta-tetrahydr ...... y disturbances in rat colitis.
@en
The effects of Delta-tetrahydr ...... y disturbances in rat colitis.
@nl
prefLabel
The effects of Delta-tetrahydr ...... y disturbances in rat colitis.
@en
The effects of Delta-tetrahydr ...... y disturbances in rat colitis.
@nl
P2093
P2860
P921
P1476
The effects of Delta-tetrahydr ...... y disturbances in rat colitis.
@en
P2093
A Molleman
J M Jamontt
M E Parsons
R G Pertwee
P2860
P304
P356
10.1111/J.1476-5381.2010.00791.X
P407
P577
2010-06-01T00:00:00Z